SCHEMBL18735191

SCHEMBL18735191

CCOC(=O)CC(=O)SC(C)C(NC(=O)CC)C(=O)N(CC)CC

nearest known ligand 0.35

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.35
▸ MGAM O43451 1/20 0.35
▸ SI P14410 1/20 0.35
▸ MGAM2 Q2M2H8 1/20 0.35
▸ KMT2A Q03164 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CYP1A2 P05177 1/20 0.30
▸ LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18735174 0.90 — —
SCHEMBL18734952 0.88 MGAM (0.33) GAAMGAMSIMGAM2KMT2A
SCHEMBL18735162 0.87 MGAM (0.35) GAAMGAMSIMGAM2KMT2A
SCHEMBL18735146 0.87 LMNA (0.32) LMNA
SCHEMBL18735073 0.85 GAA (0.40) GAAMGAMSIMGAM2KMT2A
SCHEMBL18735172 0.85 MGAM (0.33) GAAMGAMSIMGAM2
SCHEMBL18734948 0.82 — —
SCHEMBL18734949 0.80 — —
SCHEMBL18735077 0.79 KMT2A (0.35) GAAMGAMSIMGAM2KMT2A
SCHEMBL18734959 0.77 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback